SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-001915
Filing Date
2024-02-28
Accepted
2024-02-28 07:51:22
Documents
125
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K qure-20231231x10k.htm   iXBRL 10-K 3797678
2 EX-4.1 qure-20231231xex4d1.htm EX-4.1 64328
3 EX-10.74 qure-20231231xex10d74.htm EX-10.74 137759
4 EX-10.75 qure-20231231xex10d75.htm EX-10.75 144715
5 EX-10.76 qure-20231231xex10d76.htm EX-10.76 37255
6 EX-10.77 qure-20231231xex10d77.htm EX-10.77 203830
7 EX-14.1 qure-20231231xex14d1.htm EX-14.1 49955
8 EX-21.1 qure-20231231xex21d1.htm EX-21.1 8690
9 EX-23.1 qure-20231231xex23d1.htm EX-23.1 2612
10 EX-31.1 qure-20231231xex31d1.htm EX-31.1 15102
11 EX-31.2 qure-20231231xex31d2.htm EX-31.2 15022
12 EX-32.1 qure-20231231xex32d1.htm EX-32.1 12896
13 EX-97.1 qure-20231231xex97d1.htm EX-97.1 51108
14 GRAPHIC qure-20231231x10k001.jpg GRAPHIC 5737
15 GRAPHIC qure-20231231x10k002.jpg GRAPHIC 71026
16 GRAPHIC qure-20231231x10k003.jpg GRAPHIC 38611
17 GRAPHIC qure-20231231xex10d76001.jpg GRAPHIC 4982
  Complete submission text file 0001558370-24-001915.txt   16688017

Data Files

Seq Description Document Type Size
18 EX-101.SCH qure-20231231.xsd EX-101.SCH 100968
19 EX-101.CAL qure-20231231_cal.xml EX-101.CAL 93430
20 EX-101.DEF qure-20231231_def.xml EX-101.DEF 428850
21 EX-101.LAB qure-20231231_lab.xml EX-101.LAB 890243
22 EX-101.PRE qure-20231231_pre.xml EX-101.PRE 688472
127 EXTRACTED XBRL INSTANCE DOCUMENT qure-20231231x10k_htm.xml XML 2959693
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36294 | Film No.: 24690205
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)